Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
February 2026
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
Read more
1
Mins
12 Sep 2024
Early Intervention in Osteoarthritis: An Interactive Case Study
With osteoarthritis prevalence rising globally, this interactive case study was designed to highlight the patient journey of a someone with early-stage knee osteoarthritis
11
Mins
12 Sep 2024
New Developments in Clinical Trials for Osteoarthritis
Osteoarthritis (OA) is the most common arthritis worldwide, causing pain, disability, and loss of function due to chronic joint disease…
4 Sep 2024
Optimising Methotrexate – How to Achieve Maximum Results with the Anchor Drug of Rheumatoid Arthritis Therapy
Learn more about the management of patients with rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), and psoriatic arthritis…
3 Sep 2024
Optimising Methotrexate for Arthritis
Listen to three experts attending EULAR 2024, who provide their recommendations on how to optimise methotrexate therapy use across various arthritis types.
27 Aug 2024
Light Alcohol Cuts Gout Risk in Women, But Increases in Men
A RECENT study has found a link between alcohol consumption and the risk of developing gout.
14 Aug 2024
New Biomarkers Predict Disease Activity in Juvenile Arthritis
Researchers have identified two new potential biomarkers, which could be crucial in predicting disease activity in children with non-systemic juvenile idiopathic arthritis.
4 Aug 2024
Multidisciplinary Approach Mitigates Refracture Risk for Adults with Hip Fracture
Refracture risk in adult patients who sustain a hip fracture can be mitigated through a new multidisciplinary approach, including fall prevention and anti-osteoporosis medication use.
3 Aug 2024
Safely Tapering Glucocorticoids in Patients with Systemic Lupus Erythematosus
New study shows that gradual tapering of glucocorticoid steroids in mSACQ state SLE patients can be done without increasing flare risk.
Loading posts...
« Previous
1
…
27
28
29
30
31
…
83
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View